Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Sep;36(5):397-404.
doi: 10.1016/j.semnephrol.2016.05.016.

Human Papillomavirus in Kidney Transplant Recipients

Affiliations
Review

Human Papillomavirus in Kidney Transplant Recipients

Peter V Chin-Hong. Semin Nephrol. 2016 Sep.

Abstract

Human papillomavirus (HPV) is a common infection in kidney transplant recipients. HPV causes cervical, anal, vulvar, vaginal, penile and head and neck cancers. Kidney transplant recipients have a disproportionate burden of disease given prolonged immunosuppression. Given the long pre-invasive state of precancer lesions such as cervical intraepithelial neoplasia (CIN) and anal intraepithelial neoplasia (AIN) most HPV-cancers are preventable with screening and targeted treatment of disease. Pre-transplant vaccination of age-eligible kidney transplant recipients is otherwise ideal.

Keywords: HPV; Pap test; anal cancer; cervical cancer; kidney transplant; vaccine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
High-grade anal intraepithelial neoplasia (AIN) in a female kidney transplant recipient with a history of cervical intraepithelial neoplasia (CIN).
Figure 2
Figure 2
Screening for cervical intraepithelial neoplasia (CIN) and cervical cancer in the kidney transplant patient. ASC-H, atypical squamous cells, cannot exclude HSIL; ASC-US, atypical squamous cells of undetermined significance; HR HPV, high-risk HPV test; HSIL, high-grade squamous intraepithelial lesions; LSIL, low-grade squamous intraepithelial lesions.
Figure 3
Figure 3
Screening for AIN and anal cancer in the kidney transplant patient ASC-H, atypical squamous cells, cannot exclude HSIL; ASC-US, atypical squamous cells of undetermined significance; HSIL, high-grade squamous intraepithelial lesions; LSIL, low-grade squamous intraepithelial lesions.

References

    1. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59–67. - PubMed
    1. Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol. 1997;50(8):625–34. - PMC - PubMed
    1. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, Rodriguez A, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst. 2001;93(4):315–8. - PubMed
    1. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56. - PubMed
    1. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944–56. - PubMed

MeSH terms

Substances